The Only Branded Steroid Indicated for Inflammation Associated with a Range of Ocular Surface Conditions
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Nanoscope secures new US patent for Multi-Characteristic Opsin (MCO) technology platform
2
Glaucoma innovation: Eight themes to watch in 2026
3
FDA grants Fast Track Designation to Complement Therapeutics’ CTx001 for geographic atrophy
4
Ollin Biosciences reports positive head-to-head phase 1b data for OLN324 vs faricimab
5